Similarly, pathogenic mutations have been identified in SH2D1A (77), DOCK8 (78), BTK (55, 56), and IL10RA (65) in patients with XLP, AR HIES, XLA and very early onset inflammatory bowel disease, respectively, yet expression of the encoded proteins is unaffected. The gene discussed is BTK; the disease is X-linked lymphoproliferative disease.